Drug intelligence / Profile preview

GlicoPro + hydroxypropyl-methylcellulose

Development stage
Unknown
Lead developer
Devine Meditech
Modality
Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Ophthalmic
01

Overview

GlicoPro + hydroxypropyl-methylcellulose is a combination ophthalmic formulation used as an artificial tear substitute for the treatment of dry eye disease (DED). Hydroxypropyl methylcellulose (also known as hypromellose or HPMC) is a semisynthetic, inert, viscoelastic polymer that acts as a lubricant and tear film stabilizer. It promotes corneal wetting by stabilizing and thickening the precorneal tear film, prolonging its breakdown time, and protecting the ocular surface from dryness[1][7][10]. GlicoPro is described as a multimolecular complex based on proteins, sulfured and unsulfured glycosaminoglycans, and opiorphin. The addition of GlicoPro to HPMC enhances anti-inflammatory effects by significantly decreasing inflammatory markers such as cytokines (IL-20, IL-1β, TNF-α, IL-6, IL-8), MMP-9, and MCP-1 in both in vitro models and clinical studies[4]. Clinical trials have shown that this combination improves symptoms of dry eye disease more effectively than HPMC alone by increasing tear film stability and reducing ocular surface inflammation[2][4].

Brand names
GlicoPro + hydroxypropyl-methylcellulose
Other names
HPMC + GlicoProHydroxypropyl-methylcellulose and GlicoPro eyedrops

Beyond the preview

Go deeper on GlicoPro + hydroxypropyl-methylcellulose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GlicoPro + hydroxypropyl-methylcellulose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call